EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Baylor College of Medicine
Related studies linked through entity extraction aliases.
Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
- Status
- RECRUITING
- Phase
- N/A
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- Status
- RECRUITING
- Phase
- PHASE1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
- Status
- RECRUITING
- Phase
- PHASE1
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
DBS for Depression
- Status
- RECRUITING
- Phase
- NA
The PediQUEST Response Intervention Study
- Status
- COMPLETED
- Phase
- NA
Locating Biomarkers in OCD Through Behavioral Tasks
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
- Status
- RECRUITING
- Phase
- PHASE1
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Status
- RECRUITING
- Phase
- PHASE1
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prediction of Brain Injury in Premature Infants
- Status
- COMPLETED
- Phase
- N/A
Investigation of the Genetics of Hematologic Diseases
- Status
- RECRUITING
- Phase
- N/A
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1